Schedule 13G ownership disclosure

Arcus Biosciences Inc

Security class unavailable · CUSIP: 03969F109

Event date: 2018-03-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,445,461
Percent of class
8.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-016667
Form type
SC 13G
Filer
Arcus Biosciences, Inc.
CIK
CIK 1724521
Filed
Mar 23, 2018
Reporting period
Mar 14, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub